Management of Borderline Resectable Pancreatic Cancer

Surgical Oncology Clinics of North America

Volumn 19, Issue 2, 2010, Pages 359-370

  Lal, Alysandra ^a   Christians, Kathleen ^a   Evans, Douglas B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Borderline resectable pancreatic cancer; Resectability; Vascular resection

Indexed keywords

GEMCITABINE;

CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CHEMORADIOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INDUCTION CHEMOTHERAPY; MEDICAL DECISION MAKING; MONOTHERAPY; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREAS SURGERY; PATIENT SELECTION; PREOPERATIVE CARE; REVIEW; TREATMENT PLANNING; TUMOR LOCALIZATION; VEIN OCCLUSION;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 75849147865     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.11.006     Document Type: Review

References (17)

1. Katz M.H., Pisters P.W., Evans D.B., et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206 5 (2008) 833-846 [discussion: 846-8]
2. Tseng J.F., Raut C.P., Lee J.E., et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8 8 (2004) 935-949 [discussion: 949-50]
3. Tseng J.F., Tamm E.P., Lee J.E., et al. Venous resection in pancreatic cancer surgery. Best Pract Res Clin Gastroenterol 20 2 (2006) 349-364
4. Raut C.P., Tseng J.F., Sun C.C., et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246 1 (2007) 52-60
5. Exocrine pancreas. In: Greene F.L., Page D.L., Flemming I.D., et al. (Eds). AJCC Cancer staging manual. 6th edition (2002), Springer, New York 157
6. Abrams R.A., Lowy A.M., O'Reilly E.M., et al. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16 7 (2009) 1751-1756
7. Evans D.B., Farnell M.B., Lillemoe K.D., et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16 7 (2009) 1736-1744
8. Varadhachary G.R., Tamm E.P., Abbruzzese J.L., et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13 8 (2006) 1035-1046
9. Varadhachary G.R., Tamm E.P., Crane C., et al. Borderline resectable pancreatic cancer. Curr Treat Options Gastroenterol 8 5 (2005) 377-384
10. Crane C.H., Varadhachary G., Wolff R.A., et al. The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. Best Pract Res Clin Gastroenterol 20 2 (2006) 365-382
11. Lowy A.M., Lee J.E., Pisters P.W., et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226 5 (1997) 632-641
12. Jessup J.M., Steele Jr. G., Mayer R.J., et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 128 5 (1993) 559-564
13. White R., Lee C., Anscher M., et al. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 6 1 (1999) 38-45
14. Todd K.E., Gloor B., Lane J.S., et al. Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole. J Gastrointest Surg 2 2 (1998) 159-166
15. Mehta V.K., Fisher G., Ford J.A., et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J Gastrointest Surg 5 1 (2001) 27-35
16. Katz M.H., Fleming J.B., Pisters P.W., et al. Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. Ann Surg 248 6 (2008) 1098-1102
17. Cusack Jr. J.C., Fuhrman G.M., Lee J.E., et al. Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. Am J Surg 168 4 (1994) 352-354